Clinical Trial Update: Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2 [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing 25 µg vaginal misoprostol with a slow-release dinoprostone pessary for induction of labor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Induction of Labor

Drugs mentioned

• Cytotec (misoprostol) (misoprostol)
• Dinoprostone slow-release pessary (dinoprostone)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Delivery Uterine | Phase 2 | Status: COMPLETED